Torno Capital, LLC Moon Lake Immunotherapeutics Transaction History
Torno Capital, LLC
- $624 Billion
- Q3 2024
A detailed history of Torno Capital, LLC transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Torno Capital, LLC holds 10,000 shares of MLTX stock, worth $436,400. This represents 0.02% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$436,400% of portfolio
0.02%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding MLTX
# of Institutions
131Shares Held
58.4MCall Options Held
77.2KPut Options Held
63K-
Bvf Inc San Francisco, CA21.8MShares$949 Million34.86% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$371 Million30.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.98MShares$130 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$121 Million2.1% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.32MShares$101 Million0.02% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.61B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...